5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes. - Suppr | 超能文献

5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.

作者信息

Stolinsky D C, Pugh R P, Bateman J R

出版信息

Cancer Chemother Rep. 1975 Sep-Oct;59(5):1031-3.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

5-Fluorouracil (NSC-19893) therapy for pancreatic carcinoma: comparison of oral and intravenous routes.

Cancer Chemother Rep. 1975 Sep-Oct;59(5):1031-3.

2

5-fluorouracil given once weekly: comparison of intravenous and oral administration.每周给药一次的5-氟尿嘧啶：静脉注射与口服给药的比较

Cancer. 1971 Oct;28(4):907-13. doi: 10.1002/1097-0142(1971)28:4<907::aid-cncr2820280414>3.0.co;2-9.

3

Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.).采用5-氟尿嘧啶、高剂量亚叶酸钙和口服羟基脲每周给药方案治疗晚期胰腺外分泌腺癌和胆囊腺癌。意大利南部肿瘤学组（G.O.I.M.）多中心研究结果

Cancer. 1996 Sep 15;78(6):1300-7. doi: 10.1002/(SICI)1097-0142(19960915)78:6<1300::AID-CNCR19>3.0.CO;2-4.

4

Treatment of adenocarcinoma with combinations of cyclopjosphamide (NSC-26271), vincristine (NSC-67574), and 5-fluorouracil (NSC-19893).用环磷酰胺（NSC - 26271）、长春新碱（NSC - 67574）和5 - 氟尿嘧啶（NSC - 19893）联合治疗腺癌。

Cancer Chemother Rep. 1975 Mar-Apr;59(2 Pt 1):425-7.

5

Clinical pharmacology of oral and intravenous 5-fluorouracil (NSC-19893).

Cancer Chemother Rep. 1974 Sep-Oct;58(5 Pt 1):723-31.

6

Chemotherapy in pancreatic carcinoma: 5 fluorouracil (5FU) and 1,3 bis-(2 chloretjyl)-1-nitrosourea (BCNU).胰腺癌的化疗：5-氟尿嘧啶（5FU）和1,3-双（2-氯乙基）-1-亚硝基脲（卡莫司汀，BCNU）。

Ann Surg. 1974 Apr;179(4):450-3. doi: 10.1097/00000658-197404000-00012.

7

5-day iv infusion with 5-fluorouracil (5-FU; NSC-19893) for gastroenteric carcinoma after failure on weekly 5-FU therapy.在每周一次的5-氟尿嘧啶（5-FU；NSC-19893）治疗失败后，对胃肠道癌患者进行为期5天的5-氟尿嘧啶静脉输注。

Cancer Chemother Rep. 1975 Nov-Dec;59(6):1171-9.

8

Phase II trial of streptozotocin, mitomycin C, and 5-fluorouracil in adenocarcinoma of the pancreas.链脲佐菌素、丝裂霉素C和5-氟尿嘧啶用于胰腺癌的II期试验。

Cancer Clin Trials. 1980;3(4):321-4.

9

A comparison of 5-fluorouracil administered by slow infusion and rapid injection.

Cancer Res. 1972 Dec;32(12):2717-9.

10

Combined 5-fluorouracil and supervoltage radiation therapy of locally unresectable gastrointestinal cancer.5-氟尿嘧啶与超高压放射疗法联合治疗局部无法切除的胃肠道癌

Lancet. 1969 Oct 25;2(7626):865-7. doi: 10.1016/s0140-6736(69)92326-5.

引用本文的文献

1

The practical benefits of pharmacokinetics in the use of antineoplastic agents.药代动力学在抗肿瘤药物使用中的实际益处。

Cancer Chemother Pharmacol. 1980;4(3):139-45. doi: 10.1007/BF00254011.

2

The influence of cimetidine on the pharmacokinetics of 5-fluorouracil.西咪替丁对5-氟尿嘧啶药代动力学的影响。

Br J Clin Pharmacol. 1984 Sep;18(3):421-30. doi: 10.1111/j.1365-2125.1984.tb02484.x.

3

Chemotherapy of pancreatic carcinoma.

World J Surg. 1984 Dec;8(6):935-9. doi: 10.1007/BF01656035.

4

Antineoplastic drugs: clinical pharmacology and therapeutic use.抗肿瘤药物：临床药理学与治疗应用

Drugs. 1978 Jul;16(1):46-87. doi: 10.2165/00003495-197816010-00003.